Jaro
^^^^^^^^^^^^^^^^^^^
Eric:
The issue for me is not really whether BEIR-VII disparaged findings at variance with their view. Even their sleight of hand dismissal of findings from ecologic studies or in favour of hormesis is not disquieting me most. It is the flippancy they are treating those data with which superficially back their LNT postulate.
If you want to assess by yourself the scrutiny which the BEIR VII committee applied to peer reviewed data (attention: I mean data and not fit parameters) just pick two of the publications which figure very prominently (of course 'positively') in their argument.
1) Preston D L et al., Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat. Res. 158(2002)220-225
and
2) Cardis E et al., Effects of low doses and low dose rates of external radiation: Cancer mortality among nuclear workers in three countries. Radiat. Res. 142(1995)117-132
In 1) go to table 4 (pp.224-5) and pool the rows HMG and HMS - as the ICRP did which in turn is quoted by BEIR-VII, e.g., Figure 1-7, SwHaem. Then draw in a linear-linear plot of this pooled breast cancer incidence rate together with the confidence limits in units of (10^5 PY)^ 1 against organ dose in mGy.
Since we are in the radiation protection business we are interested in (chronic) exposures below 1000 mGy.

Then ask yourself who in his right mind would represent these data by a straight line through the origin with a positive slope in order to estimate the risk in this dose range from these data(!).
If you wish to learn more about BEIR-VII scrutiny; plot the SwHaem rows for the whole dose range in a log-log plot.
What do you (in contrast to BEIR VII) see?

And then ponder: Breast cancer is supposed to belong to the more easily induced radiogenic cancers; babies are considered to represent the most radiation sensitive age.
These data represent the only truly chronic medical exposure analysed so far.
If you are not yet satisfied you might wish to look at the earlier original publications of the haemangioma data (Lundell M et al., Breast cancer risk after radiotherapy in infancy: ... Radiat. Res. 151(1999)626-632.
On page 628 you will read "The statistically significant ERR was driven mainly by cases with doses >4.0 Gy."
In Lundell M et al., Breast cancer after radiotherapy for skin hemagioma in infancy. Radiat. Res. 145(1996)225-230 you will read on page 229 "It was the contribution of subjects with breast doses >1 Gy that produced a positive association between dose and the subsequent breast cancer risk.".
BEIR-VII obviously did not want to see or know.
In 2) you pick from Table III (p.125) any row you like and this time plot the SMR given together with the 95% confidence limits.
If you don't want to waste your time you concentrate on all cancers, all leukemia, leukemia except CLL, colon cancer, stomach cancer, prostate cancer, and lung cancer.
After drawing these SMRs in a linear-linear plot ask yourself what these data(!) tell you about the cancer risk of chronic low dose exposures, say below 400 mGy, and in particular how these data compare to the BEIR-VII LNT estimate in this dose range.

Any student venturing to offer me such a misrepresentation of his data(!) for a master thesis - not to speak for a PhD thesis - without providing a compelling theoretical justification I surely would have sent back to square one.
Now search BEIR-VII for such a compelling theoretical justification of LNT.

You can repeat this exercise for ref. 1) and 2) virtually for any published epidemiological study for chronic/occupational exposures where these 'raw´ data are provided and you will find the same evidence.
Unless you are preoccupied with the notion that LNT must hold, you would never approximate these data with such a line.
Unfortunately editors increasingly are satisfied with statements of fit parameters instead of presentations of data (the new Cardis paper in BMJ is a very dire case in point).
If this trend continues, you soon will be unable to come to your own conclusions and you will have to rely on committees like BEIR-VII etc.
Upon request I can supply gif-files of the graphs whose construction I described above.
Regards, Rainer
=============================================================
-----Original
Message-----
From: Jaro [mailto:jaro-10kbq@sympatico.ca]
Sent: Friday July 01, 2005 8:42 PM
To:
cdn-nucl-l@mailman1.cis.mcmaster.ca
Subject: RE: [cdn-nucl-l] Low level
radiation and cancer: BAD NEWS
-----Original Message-----
From:
Andrew Daley
Sent: Thursday, June 30, 2005 7:08 AM
Wow! Look at
the spread on the data on the composite chart!
Correct me if I am wrong
but in Stats class when that happened we were very
suspicious about drawing
solid conclusions.
Of course the media can't report that becasue it won't
sell anything
========
Andrew,
Sounds like you had a good
Stats teacher -- probably not any of the
epidemiologists that put together
that report (my impression is not that
they are malicious -- just
over-confident in the application of their
methods).
The two big
offenders on that composite chart are the Canadian and ORNL
points.
As
someone on Radsafe pointed out, "historically, Canadians had a
high
percentage of smokers, and the available cigarettes were often
"stronger"
than the U.S. brands. Also, Canada was one of the world's major
producers of
asbestos and that, too, may have an effect as it was widely used
being a
"domestic" material."
As for the ORNL point, another person
mentioned that the result might have
come from Steve Wing, a well-know
anti-nuke -- unfortunately there isn't a
proper identification of the studies
that went into producing the pooled
study (maybe BH could tell us
?).
Jaro
^^^^^^^^^^^^^^^^^^^^^
--
No virus
found in this outgoing message.
Checked by AVG Anti-Virus.
Version:
7.0.323 / Virus Database: 267.8.8/37 - Release Date:
7/1/2005
_______________________________________________
cdn-nucl-l
mailing list
cdn-nucl-l@mailman.McMaster.CA
http://mailman.McMaster.CA/mailman/listinfo/cdn-nucl-l
CONFIDENTIAL AND PRIVILEGED INFORMATION NOTICE This e-mail, and any attachments, may contain information that is confidential, subject to copyright, or exempt from disclosure. Any unauthorized review, disclosure, retransmission, dissemination or other use of or reliance on this information may be unlawful and is strictly prohibited. AVIS D'INFORMATION CONFIDENTIELLE ET PRIVILÉGIÉE Le présent courriel, et toute pièce jointe, peut contenir de l'information qui est confidentielle, régie par les droits d'auteur, ou interdite de divulgation. Tout examen, divulgation, retransmission, diffusion ou autres utilisations non autorisées de l'information ou dépendance non autorisée envers celle-ci peut être illégale et est strictement interdite. |